Informatie: Dit is niet de actueelste versie van het datamodel. Een versieoverzicht vindt u links onder Versies. De actueelste versie vindt u hier.
Informatie:
Fout:
ID
34478
Beschrijving
A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01615406
Link
https://clinicaltrials.gov/show/NCT01615406
Trefwoorden
Versies (3)
- 17-01-19 17-01-19 -
- 22-05-19 22-05-19 -
- 23-05-19 23-05-19 - Sarah Riepenhausen
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
17 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT01615406
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
male aged 21 years or older.
boolean
ID.2
Item
ability to provide signed informed consent and willingness to comply with protocol requirements.
boolean
ID.3
Item
past biopsy indicating the presence of adenocarcinoma of the prostate gland.
boolean
ID.4
Item
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
boolean
ID.5
Item
have had, or will undergo diagnostic ct or mri imaging prior to surgery.
boolean
ID.6
Item
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
boolean
ID.7
Item
participants for whom participating would significantly delay the scheduled standard of care therapy.
boolean
ID.8
Item
participants administered a radioisotope within 5 physical half lives prior to study enrollment.
boolean
ID.9
Item
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.
boolean